Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128869) titled 'Multidimensional Differential Diagnosis Study of Autoimmune Hepatitis versus Drug-Induced Liver Injury Using Serological, Radiomic, Pathological and Glycomic Approaches' on July 27.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Autoimmune hepatitis
drug-induced liver injury
Intervention:
AIH group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: AIH group:75;DILI group:75;
Countries of Recruitment:
China
To know more, visit http...